| RS2132929609 |
ANO3
|
Health Risk |
Pathogenic |
See cases, Dystonia 24 |
| RS2132929769 |
CDH23
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome, Autosomal recessive nonsyndromic hearing loss 12 |
| RS2132929805 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132930073 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132938020 |
CDH23
|
Health Risk |
Likely pathogenic |
Thyroid cancer, nonmedullary |
| RS2132938148 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132939079 |
CDH23
|
Health Risk |
Likely pathogenic |
— |
| RS2132939399 |
WT1
|
Health Risk |
Likely pathogenic |
Wilms tumor 1, Wilms tumor 1 |
| RS2132939500 |
WT1
|
Health Risk |
Pathogenic |
Drash syndrome, Wilms tumor 1 |
| RS2132940074 |
WT1
|
Health Risk |
Likely pathogenic |
Wilms tumor 1, Wilms tumor 1 |
| RS2132940635 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Pituitary adenoma 5, multiple types |
| RS2132941125 |
AGO2
|
Health Risk |
Pathogenic/Likely pathogenic |
Lessel-Kreienkamp syndrome, Lessel-Kreienkamp syndrome |
| RS2132942163 |
WT1
|
Health Risk |
Pathogenic |
Wilms tumor 1, 11p partial monosomy syndrome |
| RS2132942367 |
WT1
|
Health Risk |
Pathogenic |
Frasier syndrome, Wilms tumor 1 |
| RS2132943031 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2132943056 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2132945702 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132945762 |
CDH23
|
Health Risk |
Likely pathogenic |
Ear malformation, Usher syndrome |
| RS2132945765 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132947899 |
CDH23
|
Health Risk |
Likely pathogenic |
— |
| RS2132949774 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132949791 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132953243 |
CDH23
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2132953252 |
CDH23
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2132953500 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132953942 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132954257 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 12, Usher syndrome type 1D |
| RS2132954803 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132954843 |
WHRN
|
Health Risk |
Pathogenic |
— |
| RS2132956266 |
ABL1
|
Health Risk |
Likely pathogenic |
Congenital heart defects and skeletal malformations syndrome, Congenital heart defects and skeletal malformations syndrome |
| RS2132957763 |
WT1
|
Health Risk |
Pathogenic |
Drash syndrome, Frasier syndrome |
| RS2132957934 |
SPTAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 5 |
| RS2132965694 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132965891 |
CDH23
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 12 |
| RS2132965979 |
CDH23
|
Health Risk |
Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS2132967710 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132967767 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132967790 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132968121 |
CDH23
|
Health Risk |
Pathogenic |
Usher syndrome, Pituitary adenoma 5 |
| RS2132968572 |
CDH23
|
Health Risk |
Likely pathogenic |
— |
| RS2132968839 |
CDH23
|
Health Risk |
Likely pathogenic |
— |
| RS2132971817 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132971828 |
CDH23
|
Health Risk |
Likely pathogenic |
— |
| RS2132973641 |
HK1
|
Health Risk |
Pathogenic |
— |
| RS2132976682 |
ABCC2
|
Health Risk |
Pathogenic |
Dubin-Johnson syndrome, Dubin-Johnson syndrome |
| RS2132977459 |
CDH23
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 12, Usher syndrome type 1D |
| RS2132978502 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132978731 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132979269 |
NTRK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2132979778 |
NTRK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Obesity, hyperphagia |
| RS2132983525 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132983720 |
RET
|
Health Risk |
Likely pathogenic |
RET-related disorder, RET-related disorder |
| RS2132983724 |
CDH23
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2132984089 |
CDH23
|
Health Risk |
Pathogenic |
Pituitary adenoma 5, multiple types |
| RS2132985083 |
CDH23
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 12 |
| RS2132987446 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS2132987509 |
CDH23
|
Health Risk |
Likely pathogenic |
— |
| RS2132988609 |
CDH23
|
Health Risk |
Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS2132988621 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132988732 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132990173 |
CDH23
|
Health Risk |
Likely pathogenic |
— |
| RS2132990504 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132990828 |
CDH23
|
Health Risk |
Likely pathogenic |
— |
| RS2132991287 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5B, with muscular dystrophy |
| RS2132991341 |
PLEC
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2Q, Epidermolysis bullosa simplex 5B |
| RS2132993345 |
GNE
|
Health Risk |
Pathogenic |
GNE myopathy, Sialuria |
| RS2132994876 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2132996862 |
CDH23
|
Health Risk |
Likely pathogenic |
— |
| RS2133001222 |
CDH23
|
Health Risk |
Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS2133001560 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2133002032 |
CDH23
|
Health Risk |
Likely pathogenic |
— |
| RS2133002381 |
CDH23
|
Health Risk |
Likely pathogenic |
Usher syndrome, Usher syndrome |
| RS2133002929 |
CDH23
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 12, Pituitary adenoma 5 |
| RS2133003011 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2133003145 |
CDH23
|
Health Risk |
Pathogenic |
Pituitary adenoma 5, multiple types |
| RS2133005844 |
GNE
|
Health Risk |
Pathogenic |
GNE myopathy, Sialuria |
| RS2133006228 |
GNE
|
Health Risk |
Pathogenic |
GNE myopathy, Sialuria |
| RS2133006435 |
PLEC
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex with nail dystrophy, Epidermolysis bullosa simplex 5B |
| RS2133006451 |
RET
|
Health Risk |
Likely pathogenic |
— |
| RS2133006493 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS2133006702 |
CDH23
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 12 |
| RS2133007032 |
GNE
|
Health Risk |
Pathogenic |
GNE myopathy, Sialuria |
| RS2133007155 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2133007268 |
GNE
|
Health Risk |
Pathogenic/Likely pathogenic |
Sialuria, GNE myopathy |
| RS2133014993 |
HNRNPK
|
Health Risk |
Likely pathogenic |
Au-Kline syndrome, Au-Kline syndrome |
| RS2133017541 |
ABL1
|
Health Risk |
Pathogenic |
Congenital heart defects and skeletal malformations syndrome, Congenital heart defects and skeletal malformations syndrome |
| RS2133020093 |
HNRNPK
|
Health Risk |
Likely pathogenic |
Au-Kline syndrome, Au-Kline syndrome |
| RS2133020130 |
HNRNPK
|
Health Risk |
Likely pathogenic |
Au-Kline syndrome, Au-Kline syndrome |
| RS2133020609 |
PUS7
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2133022634 |
ABL1
|
Health Risk |
Likely pathogenic |
Congenital heart defects and skeletal malformations syndrome, Congenital heart defects and skeletal malformations syndrome |
| RS2133028167 |
HNRNPK
|
Health Risk |
Likely pathogenic |
— |
| RS2133028735 |
OGDHL
|
Health Risk |
Pathogenic |
Yoon-Bellen neurodevelopmental syndrome, Yoon-Bellen neurodevelopmental syndrome |
| RS2133029712 |
PSAP
|
Health Risk |
risk factor |
Parkinson disease 24, autosomal dominant |
| RS2133029725 |
PSAP
|
Health Risk |
Likely pathogenic |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS2133030537 |
PSAP
|
Health Risk |
Likely pathogenic |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS2133031097 |
PSAP
|
Health Risk |
Pathogenic |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS2133031639 |
PSAP
|
Health Risk |
Pathogenic |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS2133032244 |
WT1
|
Health Risk |
Likely pathogenic |
Wilms tumor 1, 11p partial monosomy syndrome |
| RS2133032257 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS2133032654 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
11p partial monosomy syndrome, Frasier syndrome |